<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00608283</url>
  </required_header>
  <id_info>
    <org_study_id>DAIT RELIVE-01</org_study_id>
    <nct_id>NCT00608283</nct_id>
  </id_info>
  <brief_title>Live Kidney Donor Study</brief_title>
  <official_title>Live Kidney Donor Study (RELIVE-01)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Resources and Services Administration (HRSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Kidney transplants from living donors now account for 40% of all the kidney transplants done
      in the United States. However, the current information on how donating a kidney can affect
      the donor's long term health needs further investigation. The purpose of this study is to
      collect data on a large number of live kidney donors and create and analyze a comprehensive
      database. Information about the number of living kidney donors, including those who have
      experienced kidney failure, heart problems, and death will be gathered for the database.
      Investigators will then use the database to identify the risks of kidney failure, associated
      conditions, and death after living donation. The database will also be used to identify
      characteristics that put donors at higher risk for health problems after donation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Kidney transplantation is the preferred treatment to dialysis for most people with kidney
      failure. However, the current waiting time to receive a kidney from a deceased donor is
      greater than 5 years in some parts of the United States. Kidneys from living donors have
      increased the number of kidneys available for transplantation and decreased the waiting
      period for those needing a transplant. Living kidney donation also provides several
      advantages over deceased donor kidneys, including more timely transplantation and longer
      function of the transplanted kidney. Despite these facts, there is inadequate information
      about whether living kidney donation may have serious adverse effects on the donor's health.
      Long-term data on the health risks of living donation are needed.

      The purpose of this study is to establish and analyze a database of information on living
      donors who have or are going to donate a kidney at three transplant centers with longstanding
      live kidney donation programs through June 2011. Donor and recipient characteristics as well
      as specific data on kidney failure, heart disease, and death will be collected. National
      databases such as the Scientific Registry of Transplant Recipients, the Social Security Death
      Master File, the National Death Index and records maintained by the Centers for Medicare and
      Medicaid Services for patients with end stage renal disease (ESRD) will be used to supplement
      data provided by the participating transplant centers. After establishing the database,
      researchers expect to 1) determine the long-term risk of live kidney donation and 2) identify
      donor characteristics associated with higher risk for health problems after donation. Death,
      cause of death, and incidence of ESRD will be compared to those rates reported by the Centers
      for Disease Control and Prevention for the U.S. population during the same time period.

      There will be no study visits for this study. Investigators will gather data from the medical
      charts of all live kidney donors from the three transplant centers through June 2011.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall mortality</measure>
    <time_frame>Throughout study</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cause-specific mortality</measure>
    <time_frame>Throughout study</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>End stage renal disease as defined in the protocol</measure>
    <time_frame>Throughout study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular and renal morbidity</measure>
    <time_frame>Throughout study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 months incidence of adverse events</measure>
    <time_frame>At 6 months after kidney donation</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8951</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Live Kidney Donors</arm_group_label>
    <description>People who are going to donate a kidney at one of the three transplant centers from August 2007 until June 2011</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        People who will donate kidneys at one of the three transplant centers between August 2007
        and June 2011
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Donated kidney at one of the three participating study centers

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra J. Taler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Nephrology and Hypertension, Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clifton Kew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hassan Ibrahim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.niaid.nih.gov/</url>
    <description>National Institute of Allergy and Infectious Diseases (NIAID)</description>
  </link>
  <link>
    <url>https://www.niaid.nih.gov/about/dait</url>
    <description>Division of Allergy, Immunology, and Transplantation (DAIT)</description>
  </link>
  <link>
    <url>http://www.hrsa.gov/</url>
    <description>Health Resources and Services Administration (HRSA)</description>
  </link>
  <link>
    <url>https://www.nhlbi.nih.gov/</url>
    <description>National Heart, Lung, and Blood Institute (NHLBI)</description>
  </link>
  <reference>
    <citation>Baid-Agrawal S, Frei UA. Living donor renal transplantation: recent developments and perspectives. Nat Clin Pract Nephrol. 2007 Jan;3(1):31-41. Review.</citation>
    <PMID>17183260</PMID>
  </reference>
  <reference>
    <citation>Fehrman-Ekholm I, Nordén G, Lennerling A, Rizell M, Mjörnstedt L, Wramner L, Olausson M. Incidence of end-stage renal disease among live kidney donors. Transplantation. 2006 Dec 27;82(12):1646-8.</citation>
    <PMID>17198252</PMID>
  </reference>
  <reference>
    <citation>Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation. 2007 Mar 15;83(5):600-6.</citation>
    <PMID>17353781</PMID>
  </reference>
  <results_reference>
    <citation>Taler SJ, Messersmith EE, Leichtman AB, Gillespie BW, Kew CE, Stegall MD, Merion RM, Matas AJ, Ibrahim HN; RELIVE Study Group. Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant. 2013 Feb;13(2):390-8. doi: 10.1111/j.1600-6143.2012.04321.x. Epub 2012 Nov 8.</citation>
    <PMID>23137211</PMID>
  </results_reference>
  <results_reference>
    <citation>Jacobs CL, Gross CR, Messersmith EE, Hong BA, Gillespie BW, Hill-Callahan P, Taler SJ, Jowsey SG, Beebe TJ, Matas AJ, Odim J, Ibrahim HN; RELIVE Study Group. Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2221-31. doi: 10.2215/CJN.07120714. Epub 2015 Oct 13.</citation>
    <PMID>26463883</PMID>
  </results_reference>
  <results_reference>
    <citation>Jowsey SG, Jacobs C, Gross CR, Hong BA, Messersmith EE, Gillespie BW, Beebe TJ, Kew C, Matas A, Yusen RD, Hill-Callahan M, Odim J, Taler SJ; RELIVE Study Group. Emotional well-being of living kidney donors: findings from the RELIVE Study. Am J Transplant. 2014 Nov;14(11):2535-44. doi: 10.1111/ajt.12906. Epub 2014 Oct 7.</citation>
    <PMID>25293374</PMID>
  </results_reference>
  <results_reference>
    <citation>Gross CR, Messersmith EE, Hong BA, Jowsey SG, Jacobs C, Gillespie BW, Taler SJ, Matas AJ, Leichtman A, Merion RM, Ibrahim HN; RELIVE Study Group. Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant. 2013 Nov;13(11):2924-34. doi: 10.1111/ajt.12434. Epub 2013 Sep 6.</citation>
    <PMID>24011252</PMID>
  </results_reference>
  <results_reference>
    <citation>Noppakun K, Cosio FG, Dean PG, Taler SJ, Wauters R, Grande JP. Living donor age and kidney transplant outcomes. Am J Transplant. 2011 Jun;11(6):1279-86. doi: 10.1111/j.1600-6143.2011.03552.x. Epub 2011 May 12.</citation>
    <PMID>21564530</PMID>
  </results_reference>
  <results_reference>
    <citation>Messersmith EE, Gross CR, Beil CA, Gillespie BW, Jacobs C, Taler SJ, Merion RM, Jowsey SG, Leichtman AB, Hong BA; RELIVE Study Group. Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes. Transplantation. 2014 Dec 27;98(12):1294-300. doi: 10.1097/TP.0000000000000360.</citation>
    <PMID>25136843</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2008</study_first_submitted>
  <study_first_submitted_qc>February 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2008</study_first_posted>
  <last_update_submitted>March 23, 2017</last_update_submitted>
  <last_update_submitted_qc>March 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney transplant</keyword>
  <keyword>Live donor transplant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>SDY289</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY289</doc_url>
      <doc_comment>ImmPort study identifier is SDY289</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>SDY289</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY289</doc_url>
      <doc_comment>ImmPort study identifier is SDY289</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>SDY289</doc_id>
      <doc_type>Study summary, -design, -demographics, -files</doc_type>
      <doc_url>http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY289</doc_url>
      <doc_comment>ImmPort study identifier is SDY289</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

